These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15712734)

  • 1. [SSRI during pregnancy and risk of fetal neurotoxicity. Follow precautions and look for other therapeutic alternatives].
    Högberg U; Wang M
    Lakartidningen; 2005 Jan 17-23; 102(3):113-5. PubMed ID: 15712734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain.
    Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Findings from selective serotonin reuptake inhibitor-exposed neonates should be interpreted with caution.
    Norton JD; Worley LL; Lowery CL
    Pediatrics; 2004 Dec; 114(6):1739-40; author reply 1740-1. PubMed ID: 15574649
    [No Abstract]   [Full Text] [Related]  

  • 4. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
    Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
    JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant.
    Nordeng H; Spigset O
    Drug Saf; 2005; 28(7):565-81. PubMed ID: 15963005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
    Pawluski JL; Galea LA; Brain U; Papsdorf M; Oberlander TF
    Pediatrics; 2009 Oct; 124(4):e662-70. PubMed ID: 19786426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function.
    Pawluski JL; Brain UM; Underhill CM; Hammond GL; Oberlander TF
    Psychoneuroendocrinology; 2012 Jul; 37(7):1019-28. PubMed ID: 22177580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SSRI use during pregnancy.
    Tran H; Robb AS
    Semin Perinatol; 2015 Nov; 39(7):545-7. PubMed ID: 26428019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of selective serotonin reuptake inhibitors in pregnancy.
    Alwan S; Friedman JM
    CNS Drugs; 2009; 23(6):493-509. PubMed ID: 19480468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?
    Koren G; Matsui D; Einarson A; Knoppert D; Steiner M
    CMAJ; 2005 May; 172(11):1457-9. PubMed ID: 15911861
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
    Ng QX; Venkatanarayanan N; Ho CYX; Sim WS; Lim DY; Yeo WS
    J Womens Health (Larchmt); 2019 Mar; 28(3):331-338. PubMed ID: 30407100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal and neonatal effects of maternal drug treatment for depression.
    Belik J
    Semin Perinatol; 2008 Oct; 32(5):350-4. PubMed ID: 18929158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third trimester fetal pulmonary artery Doppler blood flow velocity characteristics following prenatal selective serotonin reuptake inhibitor (SSRI) exposure.
    Lim K; Sanders A; Brain U; Riggs W; Oberlander TF; Rurak D
    Early Hum Dev; 2012 Aug; 88(8):609-15. PubMed ID: 22305713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal SSRI exposure: Effects on later child development.
    Hermansen TK; Melinder A
    Child Neuropsychol; 2015; 21(5):543-69. PubMed ID: 25089614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.
    Gur TL; Kim DR; Epperson CN
    Psychopharmacology (Berl); 2013 Jun; 227(4):567-82. PubMed ID: 23681158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.
    Casper RC; Gilles AA; Fleisher BE; Baran J; Enns G; Lazzeroni LC
    Psychopharmacology (Berl); 2011 Sep; 217(2):211-9. PubMed ID: 21499702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
    van der Veere CN; Bos AF
    Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2873-4. PubMed ID: 18257430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
    J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.
    Sie SD; Wennink JM; van Driel JJ; te Winkel AG; Boer K; Casteelen G; van Weissenbruch MM
    Arch Dis Child Fetal Neonatal Ed; 2012 Nov; 97(6):F472-6. PubMed ID: 23080479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.